Investor Info
Presentation
Fact sheet
Cap Table
MustGrow is publicly traded (TSXV:MGRO; OTCQB:MGROF; FRA:0C0) agricultural biotech company focused on providing natural science-based biological solutions for high value crops, including fruit & vegetable cultivation.
| CAPITAL STRUCTURE | |
|---|---|
| Basic Shares Outstanding | 70,441,359 |
| Options/RSU's/DSU's | 4,426,947 |
| Warrants | 16,862,730 |
| Convertible Debenture | 133,332 |
| Fully-Diluted Shares Outstanding | 91,846,368 |
| Insider / Advisor Ownership | 17% |
| Average Volume (3 month) | 45,000 |
| Previous Capital Spent | C$30,000,000 |
| Cash Position (as at Jun 30, 2026) | C$4,374,012 |
| Debt | C$377,063 |
FINANCIAL STATEMENTS
2026
2025
2024
2023
ANNUAL INFORMATION FORM
News Releases
MustGrow Announces Officer Appointment and Grant of DSUs
MustGrow Announces Officer Appointment and Grant of DSUs SASKATOON, Saskatchewan, Canada, September 4, 2026 – MustGrow Biologics Corp. (TSXV: MGRO) (OTC: MGROF) (FRA: 0C0) (the “Company” or “MustGrow”) today announced the appointment of Tyler Reinheimer, CPA,...
MustGrow Announces Second Quarter 2026 Financial Results
MustGrow Announces Second Quarter 2026 Financial Results Investor Webcast: Monday, August 31st at 4:00pm ET / 1:00pm PT Register/View Here: https://us02web.zoom.us/webinar/register/1317861230560/WN_oKTSGbCQR1KjX5MnyGC3kw#/registration Please join/register at...
MustGrow Receives First Milestone Payment from Bayer AG
MustGrow Receives First Milestone Payment from Bayer AG Bayer AG has paid MustGrow the first development milestone payment. The MustGrow / Bayer AG License and Collaboration Agreement, signed in December 2023, covers soil applications of MustGrow’s...